General Information of This Antibody-drug Conjugate (ADC)
ADC ID
DRG0JDRZK
ADC Name
hCD46-26
Synonyms
hCD46 26
   Click to Show/Hide
Drug Status
Investigative
Indication
In total 1 Indication(s)
Uterine sarcoma [ICD11:2C72]
Investigative
Antibody Name
Anti-CD46 mAb
 Antibody Info 
Antigen Name
Membrane cofactor protein (CD46)
 Antigen Info 
Payload Name
PNU-159682
 Payload Info 
Therapeutic Target
DNA topoisomerase 2-alpha (TOP2A)
 Target Info 
Linker Name
Maleimide based noncleavable linker 26
 Linker Info 
General Information of The Activity Data Related to This ADC
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Standard Type Value Units Cell Line Disease Model
Half Maximal Effective Concentration (EC50) 
0.1
nM
MES-SA cells
Uterine sarcoma
Half Maximal Effective Concentration (EC50) 
0.19
nM
HEK293T cells
Normal
Full List of Activity Data of This Antibody-drug Conjugate
Revealed Based on the Cell Line Data
Click To Hide/Show 2 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50) 0.10 nM Positive CD46 expression (CD46 +++/++)
Method Description
Cells were seeded at 5000 per well in a 96-well plate in complete RPMI 1640. Antibody-ZAP complexes (Advanced Targeting Systems; produced according to manufacturer's instructions) or ADCs were added to the cells and plates incubated for 72 hours and 5% carbon dioxide.
In Vitro Model Uterine sarcoma MES-SA cells CVCL_1404
Experiment 2 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal Effective Concentration (EC50) 0.19 nM Positive CD46 expression (CD46 +++/++)
Method Description
Cells were seeded at 5000 per well in a 96-well plate in complete RPMI 1640. Antibody-ZAP complexes (Advanced Targeting Systems; produced according to manufacturer's instructions) or ADCs were added to the cells and plates incubated for 72 hours and 5% carbon dioxide.
In Vitro Model Normal HEK293T cells CVCL_0063
References
Ref 1 Evaluation of PNU-159682 antibody drug conjugates (ADCs). Bioorg Med Chem Lett. 2020 Dec 15;30(24):127640. doi: 10.1016/j.bmcl.2020.127640. Epub 2020 Oct 28.

If you find any error in data or bug in web service, please kindly report it to Dr. Shen et al.